利伐沙班，366789-02-8，≥99%

中文名：利伐沙班

英文名：Rivaroxaban

中文别名：利伐沙班

英文别名：B01AF01|1429742-50-6|2-Thiophenecarboxamide, 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-|2w26|9NDF7JZ4M3|Q420262|Xarelto|MFCD11974010|N-Smc-carboxylate|L-Glutatione|RIVAROXABAN [ORANGE BOOK]|MLS006010027|Rivaroxaban|R

纯度：≥99%

货号：R125138

Cas号：366789-02-8

存储温度：-20°C储存

产品介绍：

Rivaroxaban is an oral, direct inhibitor of Factor X, being developed for the prevention and treatment of arterial and venous thrombosis with a Ki of 0.4 nM. Rivaroxaban also inhibits prothrombinase activity (IC50 = 2.1 nM). Rivaroxaban also shows a similar affinity to purified human (IC50 = 0.7 nM) and rabbit Factor X (IC50 = 0.8 nM), but a lesser potency against purified rat Factor X (IC50 = 3.4 nM). Endogenous human and rabbit Factor X in plasma is inhibited to a similar extent by Rivaroxaban (IC50 = 21 nM and 21 nM, respectively), while 14-fold higher concentrations are required in rat plasma (IC50 = 290 nM). Rivaroxaban exhibits high permeability and polarized transport across Caco-2 cells as a substrate of the P-gp, but exhibits no inhibitory effect on P-gp-mediated drμg transport up to concentrations of 100 μM in vitro.

查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/R125138.html

利伐沙班，366789-02-8，≥99%信息由上海阿拉丁生化科技股份有限公司为您提供，如您想了解更多关于利伐沙班，366789-02-8，≥99%报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途